Gene · 594857
NPS: neuropeptide S
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NPS: neuropeptide S. Genes, record 594857. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/594857
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P0C0P6 | Neuropeptide S | 89 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents27
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 55538 | P0C0P6 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 11560 | P0C0P6 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 9474 | P0C0P6 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7168 | P0C0P6 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7168 | P0C0P6 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 11560 | P0C0P6 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 9474 | P0C0P6 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 9474 | P0C0P6 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 9481 | P0C0P6 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 56599 | P0C0P6 | Espacenet |
1 to 10 of 27
See all 27 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants641
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NPS papers | Newest fiscal year |
|---|---|---|---|
| P30DA018310 | Neurometabolomics and Neuroproteomics Center on Cell-Cell Signaling | 5 | 2025 |
| R01AA014351 | The Nociceptin ORL1 System: Treatment Target for Relapse | 5 | 2025 |
| P30AG062715 | Wisconsin Alzheimer's Disease Research Center | 3 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| R01HL056470 | Neonatal Modulation of Airway Contractility | 3 | 2025 |
| R01NS038261 | Amygdala pain mechanisms | 3 | 2025 |
| R37AA017447 | Gene-environment interaction: the brain CRF system in alcohol preferring msP rats | 3 | 2025 |
| P30AG072947 | Alzheimer's Disease Research Center | 2 | 2025 |
| R35GM127121 | Cell signaling by G protein-coupled receptors | 2 | 2025 |
1 to 10 of 641Source NIH's project files
See all 641 nih grantsPapers1,321
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dynamic Changes in Serum AFP, Albumin and ALBI after Radioembolization in Patients with Unresectable Hepatocellular Carcinoma with High or Low Alpha-Fetoprotein Levels. | Jpn J Gastroenterol Hepatol | 2026 | 42788070 | PubTator, text mining | PubMed |
| Neuropsychiatric symptom-role reorganization in amyloid PET-positive Alzheimer's disease: An expanded-cohort analysis. | J Alzheimers Dis | 2026 | 42775783 | PubTator, text mining | PubMed |
| From Self-Assembly to Survival: Neuropeptide Precursor Biology in Neuroprotection. | Curr Neuropharmacol | 2026 | 42634556 | PubTator, text mining | PubMed |
| Crawling into the Unknown: Unveiling Novel Psychoactive Substances (NPSs) in the Post Pandemic Era Utilizing the NPSfinder®. | Int J Toxicol | 2026 | 42538522 | PubTator, text mining | PubMed |
| Comprehensive in vitro profiling of traditional and emerging stimulants at monoamine transporters and the 5-HT2A receptor. | Br J Pharmacol | 2026 | 42449077 | PubTator, text mining | PubMed |
| Efficiency of stabilized nitrogen mineral fertilizers for spring wheat. | Braz J Biol | 2026 | 42417763 | PubTator, text mining | PubMed |
| Clinical Efficacy of Tezepelumab in Moderate-to-Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review of Randomized Controlled Trials. | Am J Rhinol Allergy | 2026 | 42377059 | PubTator, text mining | PubMed |
| Epigenetic regulation of cardiac physiology and pathophysiology: biological sex matters. | J Cardiovasc Aging | 2026 | 42369572 | PubTator, text mining | PubMed |
| The evolution and functional significance of neuropeptide cocktails: insights from SALMFamides in asteroid echinoderms. | Open Biol | 2026 | 42336389 | PubTator, text mining | PubMed |
| Development and application of a simplified, quantitative method for 30+ New Psychoactive Substances in hair. | J Anal Toxicol | 2026 | 42296389 | PubTator, text mining | PubMed |
1 to 10 of 1,321
See all 1,321 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/594857
GET https://conductscience.org/api/genes/v1/594857/patents?page=2